Dr. William G. Kaelin, Jr., Sir Peter J. Ratcliffe, and Dr. Gregg L. Semenza won the 2019 Nobel Prize in Physiology or Medicine for their work related to a genetic condition called von Hippel-Lindau syndrome (VHL). VHL is a hereditary cancer syndrome that is associated with an increased risk for cancerous and benign tumors in…

Read More

Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk patients — identifying gene-specific cancer associations they hope will inform future hereditary cancer test guidance.

Read More

My Gene Counsel, a digital health company that provides personalized, easy-to-understand web-based genetic counseling, today announced that the company has expanded its database of genetic resources to include content for at-home genetic tests related to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease.

Read More

In this Quest Diagnostics webinar, My Gene Counsel’s Ellen Matloff describes which patients are candidates for genetic testing, summarizes the types of hereditary cancer testing available for patient management, and discusses the key personal and family history findings that determine which test is best for a particular patient.

Read More

My Gene Counsel, a digital health company that provides personalized, easy-to-understand genetic counseling reports, responded to recent statements issued by the American Society of Human Genetics (ASHG) and the American College of Medical Genetics and Genomics (ACMG) on the responsibility to recontact research participants and patients when new genetic findings emerge, by positioning its IT…

Read More